Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

6.50
Delayed Data
As of 3:59pm ET
 +0.20 / +3.17%
Today’s Change
3.22
Today|||52-Week Range
6.72
+30.52%
Year-to-Date
Top 3 Growth Stocks Under $10
Sep 29 / Zacks.com - Paid Partner Content
Here are 2 Momentous Healthcare Stocks to Buy Now
Sep 21 / Zacks.com - Paid Partner Content
PAREXEL International (PRXL) Set to Acquire ExecuPharm
Sep 27 / Zacks.com - Paid Partner Content
Adamas (ADMS) Parkinson's Disease Drug Positive in Phase III
Sep 21 / Zacks.com - Paid Partner Content
Ionis/Biogen Complete Nusinersen NDA Submission in U.S.
Sep 27 / Zacks.com - Paid Partner Content
Aldeyra Therapeutics (ALDX) Worth a Look: Stock Gains 7%
Sep 21 / Zacks.com - Paid Partner Content
Array (ARRY) Hits 52-Week High on Positive Phase III Data
Sep 27 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for September 21st
Sep 21 / Zacks.com - Paid Partner Content
Novartis Ilaris Approved for Extended Use in Periodic Fever
Sep 26 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) Gets Favorable CHMP Opinion for Olaratumab
Sep 19 / Zacks.com - Paid Partner Content
Glaxo/J&J File BLA for Rheumatoid Arthritis Drug in the U.S.
Sep 26 / Zacks.com - Paid Partner Content
Novartis (NVS) Presents Positive Data on Cardiovascular Drug
Sep 19 / Zacks.com - Paid Partner Content
Edwards Lifesciences, DaVita HealthCare Partners, Corcept Therapeutics and CryoLife h...
Sep 22 / Zacks.com - Paid Partner Content
Advanced Accelerator (AAAP) Worth Watching: Stock Jumps 6.2%
Sep 19 / Zacks.com - Paid Partner Content